Vimarsana
Biggest News Aggregation in the World

Page 34 - Zai Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zai Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zai Lab Today - Breaking & Trending Today

Earnings Scheduled For November 7, 2023 - Olaplex Hldgs (NASDAQ:OLPX), Outset Medical (NASDAQ:OM) - Vimarsana News

Earnings Scheduled For November 7, 2023 - Olaplex Hldgs (NASDAQ:OLPX), Outset Medical (NASDAQ:OM)

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Kaylyn Jackson Schiff - Vimarsana News

Kaylyn Jackson Schiff

Kaylyn Jackson Schiff’s profile on The Conversation

Series on Emerging Technology, U.S. Foreign Policy, and World Order: How Artificial Intelligence is Reshaping Our World - Vimarsana News

Series on Emerging Technology, U.S. Foreign Policy, and World Order: How Artificial Intelligence is Reshaping Our World

Panelists discuss the impact, benefits, and challenges of how artificial intelligence technologies are being adopted across sectors.PLEASE NOTE: This meeting is part of the Twenty-Eighth Annual Term …

Source: cfr.org
Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates - Vimarsana News

Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates

/PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced financial results for the third quarter...

argenx Reports Third Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

argenx Reports Third Quarter 2023 Financial Results and Provides Business Update

$329 million in third quarter global net product salesOn track to submit VYVGART® Hytrulo sBLA for CIDP by year-end 2023 Results from the ADVANCE-IV study published in The Lancet Management to host conference call today at 1:30 pm CET (8:30 am ET) October 31, 2023 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced its third quarter 2023 financial result

Source: yahoo.com